Search

Your search keyword '"Verhaak, Roel G W"' showing total 296 results

Search Constraints

Start Over You searched for: Author "Verhaak, Roel G W" Remove constraint Author: "Verhaak, Roel G W"
296 results on '"Verhaak, Roel G W"'

Search Results

2. IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy

3. Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus

7. Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response

9. AmpliconSuite: an end-to-end workflow for analyzing focal amplifications in cancer genomes

10. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers

11. Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling

13. Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine

14. Longitudinal molecular trajectories of diffuse glioma in adults

15. Circular ecDNA promotes accessible chromatin and high oncogene expression

17. PAF promotes stemness and radioresistance of glioma stem cells

18. Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: relation to grade, histopathology and overall survival in the GLASS-NL cohort

19. Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma

21. Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy

23. Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma

25. Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort

28. GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data

31. Targeting IDH in Low-Grade Glioma.

32. Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain

33. PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells

34. Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions

35. Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.

36. Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance.

37. Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAFV600E inhibition resistance in melanoma.

39. Spatial concordance of DNA methylation classification in diffuse glioma

40. Comprehensive molecular characterization of clear cell renal cell carcinoma

41. PDPN marks a subset of aggressive and radiationresistant glioblastoma cells.

43. Suppression of lung adenocarcinoma progression by Nkx2-1

44. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

45. Additional file 1 of Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma

46. Additional file 2 of Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma

47. Comprehensive genomic characterization defines human glioblastoma genes and core pathways

48. Characterizing the cancer genome in lung adenocarcinoma

49. Comparative molecular life history of spontaneous canine and human gliomas

50. Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non‐sarcomatoid renal carcinomas

Catalog

Books, media, physical & digital resources